The market for antimicrobial susceptibility testing is expected to grow at a CAGR of around 5.4% from 2020 to 2027 and expected to reach the market value of around US$ 4,764.3 Mn by 2027.
Antimicrobial Susceptibility Testing or AST is a laboratory procedure performed by medical technologists particularly to determine which antimicrobials will inhibit the growth of the bacteria or fungi causing a specific infection. The results of this test help practitioners to determine which drug is most effective to treat a person's infection. Additionally, on a large scale, it aids in the evaluation of treatment services provided by the clinics, hospitals, and national programs for the control and prevention of infectious diseases.
Market Dynamics
The rising incidence of infectious diseases across the globe coupled with epidemic & pandemic events like coronavirus are driving the market growth. The increasing research grants, funding, and public-private investments in the healthcare market especially in developing economies are supporting the market growth. The technological advancements associated with the testings and solutions in the healthcare sector are additionally bolstering the market growth. The growing government initiatives to detect and control antimicrobial-resistant species are further boosting the market value. The emergence of multidrug-resistance due to drug abuse is propelling the market value. Furthermore, awareness initiatives for antimicrobial resistance and its control are projected to create potential opportunities over the forecast period from 2020 to 2027.
On the other side, high cost associated with the automated identification (ID) and antibiotic susceptibility test (AST) systems are likely to limit the growth to an extent over the forecast period from 2020 to 2027.
Segment Instance of Global Antimicrobial Susceptibility Testing Market
Antibacterial Susceptibility Testing is leading the market with maximum revenue share
In 2019, antibacterial susceptibility testing segment by type is having potential share in the market and the segment is also projected to maintain its dominance over the forecast period from 2020 to 2027. The rapid investment and advancement in the segment is supporting its growth in the global market.
North America accounted for the maximum share (%) in the antimicrobial susceptibility testing market
In 2019, North America leads the antimicrobial susceptibility testing market with maximum share in terms of revenue, and the region is also anticipated to maintain its dominance over the forecast period from 2020 to 2027. The presence of major players in the region is the primary factor supporting the regional market value. The early adoption and investment in testing practices particularly in the US and Canada are supporting the regional market value. The US market value dominated the North America antimicrobial susceptibility testing market.
Asia Pacific is projected to exhibit fastest growth over the forecast period from 2020 to 2027
The Asia Pacific region is exhibiting the fastest growth during the forecast period on account of its rapidly developing economies including China and India. The developing healthcare sector coupled with the investment in infrastructure development, technology advancement, and an increasing number of professional practices are supporting the regional market growth. The increasing research and development activities in the region are additionally supporting the regional market growth.
Key Market Players
The players profiled in the report include Alifax, Becton Dickinson and Company (BD), Biomerieux, Bio-Rad Laboratories, Inc, Creative Diagnostics, Danaher Corporation, HiMedia Laboratories, Merck KGaA, Resistell AG, Thermo Fisher Scientific Inc, and others.
Market Segmentation
Market By Product
Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Testing Disks
- MIC Strips
- Susceptibility Testing Plates
Automated Laboratory Instruments
Culture and Growth Media
Consumables
Market By Type
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing Types (slow-growing pathogens)
Market By Application
Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other
Market By End User
Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Research & Academic Institutes
Clinical Research Organizations (CROs)
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Antimicrobial Susceptibility Testing
1.1. Definition and Scope
1.1.1. Definition of Antimicrobial Susceptibility Testing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Antimicrobial Susceptibility Testing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Antimicrobial Susceptibility Testing Market By Product
1.2.3. Antimicrobial Susceptibility Testing Market By Type
1.2.4. Antimicrobial Susceptibility Testing Market By Application
1.2.5. Antimicrobial Susceptibility Testing Market By End User
1.2.6. Antimicrobial Susceptibility Testing Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Antimicrobial Susceptibility Testing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Antimicrobial Susceptibility Testing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Antimicrobial Susceptibility Testing Market By Product
4.1. Introduction
4.2. Antimicrobial Susceptibility Testing Revenue By Product
4.2.1. Antimicrobial Susceptibility Testing Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Manual Antimicrobial Susceptibility Testing Products
4.2.2.1. Manual Antimicrobial Susceptibility Testing Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Susceptibility Testing Disks
4.2.3.1. Susceptibility Testing Disks Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. MIC Strips
4.2.4.1. MIC Strips Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Susceptibility Testing Plates
4.2.5.1. Susceptibility Testing Plates Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Automated Laboratory Instruments
4.2.6.1. Automated Laboratory Instruments Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Culture and Growth Media
4.2.7.1. Culture and Growth Media Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.8. Consumables
4.2.8.1. Consumables Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Antimicrobial Susceptibility Testing Market By Type
5.1. Introduction
5.2. Antimicrobial Susceptibility Testing Revenue By Type
5.2.1. Antimicrobial Susceptibility Testing Revenue (US$ Mn) and Forecast, By Type, 2016-2027
5.2.2. Antibacterial Susceptibility Testing
5.2.2.1. Antibacterial Susceptibility Testing Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Antifungal Susceptibility Testing
5.2.3.1. Antifungal Susceptibility Testing Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Antiparasitic Susceptibility Testing
5.2.4.1. Antiparasitic Susceptibility Testing Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Other Susceptibility Testing Types (slow-growing pathogens)
5.2.5.1. Other Susceptibility Testing Types (slow-growing pathogens) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Antimicrobial Susceptibility Testing Market Revenue By Application
6.1. Introduction
6.2. Antimicrobial Susceptibility Testing Revenue (US$ Mn) By Application
6.2.1. Antimicrobial Susceptibility Testing Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
6.2.2. Clinical Diagnostics
6.2.2.1. Clinical Diagnostics Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Drug Discovery and Development
6.2.3.1. Drug Discovery and Development Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Epidemiology
6.2.4.1. Epidemiology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Antimicrobial Susceptibility Testing Market By End User
7.1. Introduction
7.2. Antimicrobial Susceptibility Testing Revenue (US$ Mn) By End User
7.2.1. Antimicrobial Susceptibility Testing Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
7.2.2. Hospitals and Diagnostic Centers
7.2.2.1. Hospitals and Diagnostic Centers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.3.1. Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Research & Academic Institutes
7.2.4.1. Research & Academic Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Clinical Research Organizations (CROs)
7.2.5.1. Clinical Research Organizations (CROs) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Antimicrobial Susceptibility Testing Market By Country
8.1. North America Antimicrobial Susceptibility Testing Overview
8.2. U.S.
8.2.1. U.S. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.S. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.3. U.S. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.2.4. U.S. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Canada
8.3.1. Canada Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Canada Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.3. Canada Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3.4. Canada Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Antimicrobial Susceptibility Testing Market By Country
9.1. Europe Antimicrobial Susceptibility Testing Market Overview
9.2. U.K.
9.2.1. U.K. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.2. U.K. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.2.3. U.K. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.2.4. U.K. Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.3. Germany
9.3.1. Germany Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.2. Germany Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.3.3. Germany Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3.4. Germany Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.4. France
9.4.1. France Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.2. France Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.4.3. France Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4.4. France Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.5. Spain
9.5.1. Spain Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.2. Spain Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.5.3. Spain Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5.4. Spain Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.2. Rest of Europe Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.6.3. Rest of Europe Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6.4. Rest of Europe Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Antimicrobial Susceptibility Testing Market By Country
10.1. Asia Pacific Antimicrobial Susceptibility Testing Market Overview
10.2. China
10.2.1. China Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.2.2. China Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.3. China Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.2.4. China Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Japan
10.3.1. Japan Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.3.2. Japan Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.3. Japan Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3.4. Japan Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. India
10.4.1. India Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.4.2. India Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.3. India Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4.4. India Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.5. Australia
10.5.1. Australia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.5.2. Australia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.3. Australia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5.4. Australia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.6.2. South Korea Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.3. South Korea Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6.4. South Korea Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.7.2. Rest of Asia-Pacific Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.3. Rest of Asia-Pacific Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7.4. Rest of Asia-Pacific Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Antimicrobial Susceptibility Testing Market By Country
11.1. Latin America Antimicrobial Susceptibility Testing Market Overview
11.2. Brazil
11.2.1. Brazil Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
11.2.2. Brazil Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.3. Brazil Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.2.4. Brazil Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
11.3.2. Mexico Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.3. Mexico Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3.4. Mexico Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
11.4.2. Rest of Latin America Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.3. Rest of Latin America Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 12. Middle East & Africa Antimicrobial Susceptibility Testing Market By Country
12.1. Middle East & Africa Antimicrobial Susceptibility Testing Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
12.2.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.3. Saudi Arabia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.2.4. Saudi Arabia Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.3. UAE
12.3.1. UAE Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
12.3.2. UAE Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.3. UAE Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3.4. UAE Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
12.4.2. Rest of Middle East & Africa Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.3. Rest of Middle East & Africa Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4.4. Rest of Middle East & Africa Antimicrobial Susceptibility Testing Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
CHAPTER 13. Player Analysis Of Antimicrobial Susceptibility Testing
13.1. Antimicrobial Susceptibility Testing Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Antimicrobial Susceptibility Testing Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Alifax
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Alifax 2019 Antimicrobial Susceptibility Testing Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Becton Dickinson and Company (BD)
14.3. Biomerieux
14.4. Bio-Rad Laboratories, Inc
14.5. Creative Diagnostics
14.6. Danaher Corporation
14.7. HiMedia Laboratories
14.8. Merck KGaA
14.9. Resistell AG
14.10. Thermo Fisher Scientific Inc
14.11. Others
